Different renal effects of two inhibitors of catechol-O-methylation in the rat: Entacapone and CGP 28014

Acta Physiologica Scandinavica

Volumn 162, Issue 4, 1998, Pages 489-494

  Hansell, P ^a   Odlind, C ^a   Mannisto P T ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Catechol o methyl transferase; Dihydroxyphenylacetic acid; Dopamine; Entacapone; Kidney; Sodium

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE; ENTACAPONE; N (6 OXO 1H PYRID 2 YL) N',N' DIPROPYLFORMAMIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; SODIUM URINE LEVEL; URINARY EXCRETION; URINE OSMOLALITY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; AMIDINES; ANIMALS; BLOOD PRESSURE; CATECHOL O-METHYLTRANSFERASE; CATECHOLS; DOPAMINE; DOPAMINE ANTAGONISTS; ENZYME INHIBITORS; GLOMERULAR FILTRATION RATE; KIDNEY; MALE; PYRIDONES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM;

EID: 0031969101     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1998.00319.x     Document Type: Article

References (14)

1. Aperia, A. et al. 1996. Cellular mechanisms for bi-directional regulation of tubular sodium reabsorption. Kidney Int 49, 1743-1747.
2. Aperia, A., Meister, B. & Hökfelt, T. 1991. Dopamine: An intrarenal natriuretic hormone. In: Goldfarb, S. & Ziyadeh FN. & Stein, JH. (eds), Contemporary Issues in Nephrology, Vol. 23, pp. 315-338. New York: Churchill Livingstone Inc.
3. +-ATPase. Kidney Int 52, 742-747.
4. Hansell, P., Andén, N.-E., Grabowska-Andén, M. & Ulfendahl, H.R. 1988. Atrial natriuretic factor, urinary catechol compounds and electrolyte excretion during normal hydration and isotonic volume expansion. Influence of dopamine receptor blockade. Acta Physiol Scand 134, 421-428.
5. Hansell, P. & Fasching, A. 1991. The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia. Kidney Int 39, 253-258.
6. José, P.A., Raymond, J.R., Bates, M.D., Aperia, A., Felder, R.A. & Carey, R.M. 1992. The renal dopamine receptors. J Am Soc Nephrol 2, 1265-1278.
7. Kaakkola, S., Gordin, A. & Männistö, P.T. 1994. General properties and clinical possibilities of new selective inhibitors of catechol-O-methyltransferase. Gen Pharmacol 25, 813-824.
8. Lee, M.R. 1989. Dopamine, the kidney and essential hypertension. Clin Exp The Pract A11 (Suppl. 1), 149-158.
9. Lee, M.R. 1993. Dopamine and the kidney: Ten years on. Clin Sci 84, 357-375.
10. Männistö, P.T., Tuomainen, P. & Tuominen, R.K. 1992. Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat. Br J Pharmacol 105, 569-574.
11. Törnwall, M. & Männistö, P.T. 1993. Effects of three types of catechol-O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats. Eur J Pharmacol 250, 77-84.
12. Waldmeier, P.C., et al. 1990. CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure. Naunyn-Schmiedeberg's Arch Pharmacol 342, 305-311.
13. Whitfield, I., Sowers, J.R., Tuck, M.L. & Golub, M.S. 1980. Dopaminergic control of plasma catecholamine and aldosterone responses to acute stimuli in man. J Clin Endocrinol Metab 51, 724-729.
14. Yoshimura, M., Ikegaki, I., Nishimura, M. & Takahashi, H. 1990. Role of dopaminergic mechanisms in the kidney for the pathogenesis of hypertension. J Auto Pharmacol 10 (Suppl. 1), 67-72.